University of Rochester Medical Center Wilmot Cancer Center
Strong Memorial Hospital
Rochester, NY
Filters
Save & Share
Clear Filters
Diagnosis
Purpose of Trial
Filter and find trials based on their purpose.
Risk Level
Enter this patient's risk level (IPSS-R / IPSS-M).
Accepting patients
APP SICP
An Inpatient Advanced Care Practitioner-delivered Advance Care Planning Intervention for Older Patients With Hematologic Malignancies
Learn more- Pilot Trial
Accepting patients
MRD
A Program for Monitoring Minimal Residual Disease Following Treatment of Patients With Acute Myeloid Leukemia or High Grade Myelodysplastic Syndrome
Learn more- Minimal Residual Disease (MRD)
Accepting patients
HBO-UBC
A Randomized Phase II Study Evaluating the Efficacy of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplantation
Learn more- Cord Blood
- Phase 2
Accepting patients
Mismatched Related vs. Matched Unrelated Donor
A Multi-Center, Phase 3, Randomized Trial of Matched Unrelated Donor (MUD) Versus HLA-Haploidentical Related (Haplo) Myeloablative Hematopoietic Cell Transplantation for Children, Adolescents, and Young Adults (AYA) With Acute Leukemia or Myelodysplastic Syndrome (MDS)
Learn more- Allogeneic Stem Cell Transplant
- Monoclonal Antibody
- Phase 3
Accepting patients
Hyperbaric Oxygen Therapy
A Pilot Study to Determine the Safety and Efficacy of Incorporating Hyperbaric Oxygen Therapy Into RIC Fludarabine and Melphalan and Allogeneic Hematopoietic Stem/Progenitor Transplantation
Learn more- Allogeneic Stem Cell Transplant
- Phase 1
Accepting patients
PedAL Screening
Pediatric Acute Leukemia (PedAL) Screening Trial - Developing New Therapies for Relapsed Leukemias
Learn more- Phase 1/2
Accepting patients
Umbilical Cord Blood Transplantation
Umbilical Cord Blood Transplantation From Unrelated Donors
Learn more- Cord Blood
- Phase 1
Accepting patients
TeleSICP
A Telehealth Advance Care Planning Intervention for Older Patients With Myeloid Malignancies: A Pilot Randomized Controlled Trial
Learn more- Phase 1